Kojouharoff, G.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

The Limits of Jurisprudence Definedby Jeremy Bentham

Review by: C. D. Kojouharoff

Journal:

Columbia Law Review

Year:

1945

Language:

english

File:

PDF, 390 KB

english, 1945

2

Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study

Kropff, Martin, Vogel, Martin, Bisping, Guido, Schlag, Rudolf, Weide, Rudolf, Knauf, Wolfgang, Fiechtner, Heinrich, Kojouharoff, Georgi, Kremers, Stephan, Berdel, Wolfgang E.

Journal:

Annals of Hematology

Year:

2017

Language:

english

File:

PDF, 490 KB

english, 2017

3

Initial clinical results with technetium-99m-labeled ll2 monoclonal antibody fragment in the radioimmunodetection of b-cell lymphomas

R. P. Baum, A. Niesen, A. Hertel, S. Adams, G. Kojouharoff, D. M. Goldenberg, G. Hör

Journal:

Year:

1994

Language:

english

File:

PDF, 441 KB

english, 1994

4

Internalization of interleukin 1 (IL 1) correlates with IL 1-induced IL 2 receptor expression and IL 2 secretion of EL4 thymoma cells

Ilka Von Hoegen, Werner Falk, Georgi Kojouharoff, Peter H. Krammer

Journal:

European Journal of Immunology

Year:

1989

Language:

english

File:

PDF, 753 KB

english, 1989

5

Interferon-gamma (IFN-γ)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice

OBERMEIER, KOJOUHAROFF, HANS, SCHÖLMERICH, GROSS, FALK

Journal:

Clinical & Experimental Immunology

Year:

1999

Language:

english

File:

PDF, 110 KB

english, 1999

6

Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of HIV-infected persons

R. G. Geissler, O. G. Ottmann, M. Eder, G. Kojouharoff, D. Hoelzer, A. Ganser

Journal:

Annals of Hematology

Year:

1991

Language:

english

File:

PDF, 456 KB

english, 1991

7

Experimental-Statistical Method for Investigation of Multicomponent Yttrium Garnet Systems

V. KOJOUHAROFF, H. IONCHEV

Journal:

Journal of the American Ceramic Society

Year:

1986

Language:

english

File:

PDF, 319 KB

english, 1986

8

Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice

G. KOJOUHAROFF, W. HANS, F. OBERMEIER, D. N. MA¨NNEL, T. ANDUS, J. SCHO¨LMERICH, V. GROSS, W. FALK

Journal:

Clinical & Experimental Immunology

Year:

1997

Language:

english

File:

PDF, 709 KB

english, 1997

9

Dextrane-sulfate (DSS-) induced chronic colitis in mice: An animal model to test anti-cytokine strategies in therapy

G. Kojouharoff, W. Hans, D.N. Männel, J. Schölmerich, V. Gross, W. Falk

Journal:

Gastroenterology

Year:

1995

Language:

english

File:

PDF, 170 KB

english, 1995

10

Distribution and infection of langerhans cells in the skin of HIV-infected healthy subjects and AIDS patients

Müller, H., Weier, S., Kojouharoff, G., Grez, M., Berger, S., Kappus, R., Shah, P.M., Stutte, H.J., Schmidts, H.L.

Journal:

Research in Virology

Year:

1993

Language:

english

File:

PDF, 1.58 MB

english, 1993

11

Mucosal damage in chronic DSS-colitis mice is mediated by IL-12 and prevented by IL-10

Obermeier, F., Kojouharoff, G., Schölmerich, J., Gross, V., Falk, W.

Journal:

Gastroenterology

Year:

1998

Language:

english

File:

PDF, 179 KB

english, 1998

12

Infection of granulocyte/monocyte progenitor cells with HIV1

Kojouharoff, G, Ottmann, O.G, von Briesen, H, Geissler, G, Rübsamen-Waigmann, H, Hoelzer, D, Ganser, A

Journal:

Research in Virology

Year:

1991

Language:

english

File:

PDF, 1.38 MB

english, 1991

13

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104)

Heinemann, V., Vehling-Kaiser, U., Waldschmidt, D., Kettner, E., Marten, A., Winkelmann, C., Klein, S., Kojouharoff, G., Gauler, T. C., von Weikersthal, L. F., Clemens, M. R., Geissler, M., Greten, T.

Journal:

Year:

2013

Language:

english

File:

PDF, 458 KB

english, 2013

14

Influence of Human Recombinant Interferon-Alpha and Interferon-Gamma on Bone Marrow Progenitor Cells of HIV-Positive Individuals

GEISSLER, R.G., OTTMANN, O.G., KOJOUHAROFF, G., REUTZEL, P., EDER, M., HOELZER, D., GANSER, A.

Journal:

AIDS Research and Human Retroviruses

Year:

1992

Language:

english

File:

PDF, 717 KB

english, 1992

15

TIBO R82913, A New HIV-1 Inhibiting Agent, Does Not Inhibit Hematopoietic Progenitor Cells

GEISSLER, R.G., GANSER, A., OTTMANN, O.G., KOJOUHAROFF, G., REUTZEL, P., ANDRIES, K., SCHELLEKENS, K., HOELZER, D.

Journal:

AIDS Research and Human Retroviruses

Year:

1991

Language:

english

File:

PDF, 469 KB

english, 1991

16

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104

Boeck, S, Jung, A, Laubender, R P, Neumann, J, Egg, R, Goritschan, C, Vehling-Kaiser, U, Winkelmann, C, Fischer von Weikersthal, L, Clemens, M R, Gauler, T C, Märten, A, Klein, S, Kojouharoff, G, Barn

Journal:

British Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 250 KB

english, 2013

17

Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104

Kruger, Stephan, Boeck, Stefan, Heinemann, Volker, Laubender, Ruediger P., Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Märten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff,

Journal:

Acta Oncologica

Year:

2015

Language:

english

File:

PDF, 531 KB

english, 2015

18

Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer

Boeck, S., Hoehler, T., Seipelt, G., Mahlberg, R., Wein, A., Hochhaus, A., Boeck, H.-P., Schmid, B., Kettner, E., Stauch, M., Lordick, F., Ko, Y., Geissler, M., Schoppmeyer, K., Kojouharoff, G., Golf,

Journal:

Annals of Oncology

Year:

2008

Language:

english

File:

PDF, 131 KB

english, 2008

19

O-0003 * P-ERK, P-AKT AND P53 AS TISSUE BIOMARKERS IN ERLOTINIB-TREATED PATIENTS WITH ADVANCED PANCREATIC CANCER: A TRANSLATIONAL SUBGROUP ANALYSIS FROM AIO-PK0104

Boeck, S., Siveke, J., Ormanns, S., Laubender, R., Jung, A., Haas, M., Vehling-Kaiser, U., Winkelmann, C., von Weikersthal, L. F., Clemens, M., Gauler, T., Marten, A., Klein, S., Kojouharoff, G., Geis

Journal:

Annals of Oncology

Year:

2013

Language:

english

File:

PDF, 32 KB

english, 2013

20

Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’

Boeck, Stefan, Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Märten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff, Georgi, Gauler, Thomas, Fischer von Weikersthal, Ludwig, Cle

Journal:

Anti-Cancer Drugs

Year:

2010

Language:

english

File:

PDF, 140 KB

english, 2010